AFL - Aflac - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0010551028
Life Insurance, Health Insurance, Cancer Insurance, Disability Insurance
Aflac Incorporated is a leading provider of supplemental health and life insurance products, operating through two main segments: Aflac Japan and Aflac U.S.
In Japan, Aflac offers a diverse range of products, including cancer, medical, and nursing care insurance, as well as whole and term life insurance. Additionally, the company provides WAYS and child endowment plans under saving type insurance products, catering to the unique needs of the Japanese market.
In the United States, Aflac U.S. offers a comprehensive suite of products, including cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance. This enables individuals and families to customize their insurance coverage to suit their specific needs and circumstances.
Aflac's products are sold through a network of sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies, providing customers with convenient access to its insurance solutions.
With a rich history dating back to 1955, Aflac Incorporated is headquartered in Columbus, Georgia, and has established itself as a trusted and reliable insurance provider. For more information, visit https://www.aflac.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
AFL Stock Overview
Market Cap in USD | 61,099m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC SubIndustry | Life & Health Insurance |
TER | 0.00% |
IPO / Inception | 1984-07-19 |
AFL Stock Ratings
Growth 5y | 91.2 |
Fundamental | 7.88 |
Dividend | 60.3 |
Rel. Performance vs Sector | 2.03 |
Analysts | 3.08/5 |
Fair Price Momentum | 125.39 USD |
Fair Price DCF | 142.86 USD |
AFL Dividends
Dividend Yield 12m | 1.73% |
Yield on Cost 5y | 4.13% |
Dividends CAGR 5y | 9.24% |
Payout Consistency | 98.0% |
AFL Growth Ratios
Growth 12m | 42.27% |
Growth Correlation 12m | 90.8% |
Growth Correlation 3m | 95.5% |
CAGR 5y | 19.03% |
CAGR/Mean DD 5y | 2.10 |
Sharpe Ratio 12m | 1.89 |
Alpha vs SP500 12m | 0.99 |
Beta vs SP500 5y weekly | 1.25 |
ValueRay RSI | 40.74 |
Volatility GJR Garch 1y | 21.60% |
Price / SMA 50 | 3.81% |
Price / SMA 200 | 23.5% |
Current Volume | 2563.8k |
Average Volume 20d | 2448.4k |
External Links for AFL Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 10, 2024, the stock is trading at USD 111.06 with a total of 2,563,794 shares traded.
Over the past week, the price has changed by -2.78%, over one month by +1.52%, over three months by +25.48% and over the past year by +42.16%.
According to ValueRays Forecast Model, AFL Aflac will be worth about 137.6 in October 2025. The stock is currently trading at 111.06. This means that the stock has a potential upside of +23.88%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 98.8 | -11.0 |
Analysts Target Price | 77.1 | -30.6 |
ValueRay Target Price | 137.6 | 23.9 |